欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2675/002
药品名称
Triplo Citrus
活性成分
acetylsalicylic acid 500.0 mg
Caffeine 50.0 mg
剂型
Effervescent tablet
上市许可持有人
Orifarm Generics A/S Energivej 15 5260 Odense Denmark
参考成员国 - 产品名称
Denmark (DK)
Triplo Cirtus
互认成员国 - 产品名称
Iceland (IS)
Triplo Citrus 500mg/50 mg freyðitafla
许可日期
2017/07/04
最近更新日期
2024/10/28
药物ATC编码
N02BA51 acetylsalicylic acid, combinations excl. psycholeptics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Non Prescription (including OTC)
附件文件下载
Final Labelling
|
Triplo Citrus LAB ENG
Date of last change:2025/01/07
PubAR
|
Final PAR Triplo_Triplo Citrus effervescent tablets DKH2675_001_002_DC
Date of last change:2024/09/06
PubAR Summary
|
Final sPAR Triplo_Triplo Citrus effervescent tablets DKH2675_001_002_DC
Date of last change:2024/09/06
Final PL
|
Triplo_Citrus_OTC_PIL_Clean
Date of last change:2024/09/06
Final PL
|
Triplo_Citrus_RX_PIL_Clean
Date of last change:2024/09/06
Final SPC
|
Triplo_Citrus_SPC_Clean
Date of last change:2024/09/06
Final PL
|
Triplo_OTC_PIL_Clean
Date of last change:2024/09/06
Final PL
|
Triplo_RX_PIL_Clean
Date of last change:2024/09/06
Final SPC
|
Triplo_SPC_Clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase